BioCentury | Feb 11, 2013
Clinical News

TO-194SL regulatory update

...Torii Pharmaceutical Co. Ltd. (Tokyo:4551, Tokyo, Japan) submitted an NDA in Japan last December for TO-194SL...
...marketing of products developed by Japan Tobacco. Japan Tobacco Inc. (Tokyo:2914; Osaka:2914), Tokyo, Japan Product: TO-194SL...
Items per page:
1 - 1 of 1